William P. Sheridan
Corporate Officer/Principal bij BIOCRYST PHARMACEUTICALS, INC.
Vermogen: 34 056 $ op 29-02-2024
Profiel
William P.
Sheridan occupies the position of Chief Development Officer at BioCryst Pharmaceuticals, Inc.
In the past Dr. Sheridan occupied the position of Vice President-North American Medical Affairs at Amgen, Inc. and Head-Bone Marrow Transplant Service at Royal Melbourne Hospital.
William P.
Sheridan received a doctorate from the University of Melbourne.
Bekende belangen in openbare bedrijven
Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
---|---|---|---|---|
17-04-2023 | 6 049 ( 0.00% ) | 34 056 $ | 29-02-2024 |
Actieve functies van William P. Sheridan
Bedrijven | Functie | Begin |
---|---|---|
BIOCRYST PHARMACEUTICALS, INC. | Corporate Officer/Principal | 15-09-2022 |
Eerdere bekende functies van William P. Sheridan
Bedrijven | Functie | Einde |
---|---|---|
AMGEN INC. | Chief Tech/Sci/R&D Officer | 01-11-2007 |
Royal Melbourne Hospital
Royal Melbourne Hospital Hospital/Nursing ManagementHealth Services Royal Melbourne Hospital owns and operates a hospital. The private company is based in Parkville, Australia. | Corporate Officer/Principal | - |
Opleiding van William P. Sheridan
University of Melbourne | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 2 |
---|---|
AMGEN INC. | Health Technology |
BIOCRYST PHARMACEUTICALS, INC. | Health Technology |
Bedrijven in privébezit | 1 |
---|---|
Royal Melbourne Hospital
Royal Melbourne Hospital Hospital/Nursing ManagementHealth Services Royal Melbourne Hospital owns and operates a hospital. The private company is based in Parkville, Australia. | Health Services |